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Abstract
Background: Continued smoking after cancer adversely affects quality of life and survival, but one fifth of cancer
survivors still smoke. Despite its demands, cancer presents an opportunity for positive behaviour change. Smoking
often occurs in social groups, therefore interventions which target families and individuals may be more successful.
This qualitative study explored patients, family members and health professionals’ views and experiences of smoking
and smoking cessation after cancer, in order to inform future interventions.
Methods: In-depth qualitative interviews (n = 67) with 29 patients, 14 family members and 24 health professionals.
Data were analysed using the ‘Framework’ method.
Results: Few patients and family members had used National Health Service (NHS) smoking cessation services and more
than half still smoked. Most recalled little ‘smoking-related’ discussion with clinicians but were receptive to talking openly.
Clinicians revealed several barriers to discussion. Participants’ continued smoking was explained by the stress of diagnosis;
desire to maintain personal control; and lack of connection between smoking, cancer and health.
Conclusions: A range of barriers to smoking cessation exist for patients and family members. These are insufficiently
assessed and considered by clinicians. Interventions must be more effectively integrated into routine practice.
Keywords: Smoking cessation, Patients, Health professionals, Family members, Cancer, Qualitative research
Background
Cancer survival is significantly worse in smokers [1, 2],
and stopping smoking after cancer diagnosis improves
survival in a number of tumour types [3]. A systematic
review of the influence of smoking cessation on prognosis
after early stage lung cancer diagnosis found that five-year
survival rates in 65 year old patients were estimated to be
33% in continuing smokers and 70% in those who stopped
[4]. Continued smoking after diagnosis produces a range
of adverse outcomes [5], including greater treatment
toxicity [6] and reduced quality of life [7].
Despite the fact that people who do stop smoking after
a cancer diagnosis can derive clear physical and psycho-
logical benefits [5], surveys suggest that around 20%
overall continue to smoke [8–10], and that this is more
likely in younger people, sexual minority groups [11]
and those without a partner [12]. A recent study from
the United States (US) suggests that one tenth are still
smoking 9 years later [13]. Few data exist on how many
survivors access smoking cessation services although we
know that the vast majority of smokers in general popu-
lations want to stop in any given year, although the
proportion varies between countries [14]. In addition,
people who do use cessation services are more likely to
stop and remain abstinent [15].
There is an extensive literature on the role of healthcare
workers in providing smoking cessation interventions,
* Correspondence: mary.wells@stir.ac.uk
1NMAHP Research Unit, University of Stirling, Scion House, Stirling FK9 4HN,
UK
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wells et al. BMC Cancer  (2017) 17:348 
DOI 10.1186/s12885-017-3344-z
illustrating the importance of infrastructure and managerial
support [16], education and feedback directed at how to
talk about smoking and how to implement evidence-based
smoking interventions [17–20], as well as efficient referral
and monitoring systems [16]. However, there is still a
significant lack of research into smoking cessation interven-
tions in the cancer field [5, 21].
The period around a cancer diagnosis presents an
opportunity for behaviour change in patients [22] and
family members [23]. Recent studies have found higher
‘quit rates’ in smokers with cancer compared to smokers
in the general population [24], indicating that they may
be more receptive to cessation support. Indeed, the po-
tential reach and uptake of smoking cessation services
may be increased in smokers who have cancer [25].
However, cancer diagnosis is emotionally demanding for
most people and consequently, smoking cessation inter-
vention strategies must be sensitive to the multiple prob-
lems faced by patients and their families. Interventions
also need to take account of the beliefs, prescribing
behaviours and approach of health professionals towards
smoking cessation in cancer patients, which may be less
than optimal [26–28]. International surveys of cancer
clinicians confirm that only a minority routinely offer or
refer patients to smoking cessation support [29, 30]. Few
qualitative studies have explored either the reasons for
this or how patients feel about smoking cessation in the
context of a cancer diagnosis [31]. To our knowledge,
there are no studies of the views and experiences of
family members who smoke.
Cancer has a significant impact on patients’ friends
and family members, and psychological interventions
oriented to the family unit can have beneficial effects on
a range of caregiver outcomes [32]. Smoking (and non-
smoking) are often part of the identity of a social group
and so can act either as a barrier or facilitator to smok-
ing interventions [33], and studies show that family
members of people with cancer are more likely to be
motivated to quit [34] and more likely to access
smoking cessation services [35]. However, despite
clear evidence that family members’ beliefs and be-
haviour influence smoking cessation [33, 36, 37],
current primary prevention interventions focus almost
exclusively on individuals, and there has been very
little research conducted on the particular issues
facing patients and family members who smoke, after
a recent cancer diagnosis.
In order to inform interventions that are sensitive
to the cancer context and likely to be effective at
reducing smoking in practice, this study explored the
experiences and views of patients, family members
and health care professionals towards smoking and
smoking cessation around the time of cancer
diagnosis.
Methods
We conducted a qualitative study in Scotland using
in-depth interviews, in order to develop the theoretical
and empirical basis of an intervention to improve uptake
of existing effective smoking cessation services: an
approach consistent with the United Kingdom’s Medical
Research Council (MRC) complex interventions framework
[38, 39]. National Health Service (NHS) management and
ethics approval were granted (13/ES/0032–22/5/13 and 6/
6/13). Our research questions were: -
1. What are cancer patients’ and family members’
experiences of engaging with current NHS smoking
cessation services, and which forms and constituent
characteristics of such services were found helpful
or unhelpful?
2. What do patients and family members who have not
previously engaged with smoking services believe are
the key barriers and potential facilitators to encouraging
successful uptake of current forms of smoking cessation
services in the first 6 months after a cancer diagnosis?
3. What do health professionals believe are the key
barriers and facilitators to discussing smoking
cessation with patients and family members in the
first 6 months after a cancer diagnosis?
4. What are health professionals’ views regarding the
organisational, psychosocial, ethical and clinical factors
that may affect delivery, uptake and engagement with
smoking cessation services, among patients with cancer
and their family members?
5. What are the key characteristics and dimensions of a
context-sensitive intervention that would render it
acceptable, feasible and effective in increasing uptake
of smoking cessation services (from the perspectives
of patients, family members and health
professionals)?
Recruitment and sampling strategy
Three samples were recruited: patients, family members
and health professionals. Inclusion criteria for our pa-
tient sample were: adults over 18 years of age who could
speak English; more than 2 weeks but less than 3 years
from diagnosis of lung, head & neck, colorectal or
cervical cancer; on active follow up; and currently smoke
or smoked until diagnosis. We excluded patients who
were judged by the clinical team to be too distressed to
participate.
One member of the team (PA) screened hospital clinic
records to identify eligible patients, who were then
approached at out-patient clinics. Patients willing to par-
ticipate completed a screening questionnaire to assess:
current smoking, smoking dependency, intention to stop
smoking, use of cessation services and family structure
(see Table 1). Recruitment aimed to achieve sampling
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diversity in relation to age, gender, diagnosis, treatment
intent, socio-economic status (as indicated by Scottish
Index of Multiple Deprivation (SIMD) [40]), time since
diagnosis and current smoking status. Recruitment (and
interviews) took place over a 16 month period and sam-
pling diversity was achieved by continuing to screen for
eligible patients firstly by cancer type (by attending
different cancer outpatient clinics and screening case
notes for eligible patients) and then inviting all eligible
patients to participate until target numbers were
reached. The socioeconomic diversity of the sample
reflected the patient demographic of clinic attenders.
Family members or partners/close friends of cancer
patients were eligible to take part if they were smokers/re-
cent ex-smokers. Due to difficulties in achieving target
numbers in this group, recruitment used a range of
strategies: patients nominated one or two close relatives
or friends who were smokers or recent ex-smokers at the
time of interview; family members were given information
about the study directly by a researcher or nurse; advertis-
ing the study in a local newspaper; and advertising the
study within smoking cessation groups (see Table 2). Only
family members (rather than close friends of patients)
took part in interviews.
Drawing on research team clinical expertise, a purpos-
ive sample of health professionals involved in cancer and
smoking cessation services were identified in order to
seek the views of a range of professionals who might
inform the study. This included oncologists, clinical
nurse specialists, therapy radiographers, pharmacists,
clinic and ward nurses, General Practitioners (GPs) and
smoking cessation advisors.
Invitation letters and information sheets were distrib-
uted at clinics, sent via email to professionals or posted
to those responding to the newspaper advertisement. In-
terested professionals, patients or family members were
Table 1 Screening questionnaire used in recruitment and sampling
Are you a current smoker or a recent ex-smoker (i.e. since diagnosis)?
Smoker/Recent ex-smoker
How many cigarettes per day did you smoke over the 6 months prior to
diagnosis and how soon after waking did you smoke?
Do you have at least one close family member who is either a current
smoker or who stopped smoking after your diagnosis? Y/N
Does your family member live with or apart from you? W/A
Have you or your family member had any previous experience of using
smoking cessation services? Patient Y/N Family member Y/N
Are you or your family members currently considering smoking
cessation?
Patient Y/N Family member Y/N
Stage Diagnosis stage/Treatment stage/Follow-up
Period since diagnosis:
Age
Table 2 Characteristics of study participants (Patients and
Family Members)
Patients
(n = 29)
Family Members
(n = 14)
Gender:
Female 13 8
Male 16 6
Age:
30–50 yrs 5 4
51–60 yrs 7 3
61–70 yrs 12 5
71–80 yrs 5 1
81–90 yrs 0 1
Place of recruitment:
Via oncology clinic 29 9
Via newspaper advertisement N/A 3
Via NHS Smoking Cessation Group N/A 2
Relationship of family member to patient participant:
Spouse/partner N/A 5
Daughter 1
Parents 2
Sister 1
Recruited independently of patient 5
Scottish Index of Multiple Deprivation (SIMD): 2012 Quintile:
1 (Most deprived) 7 8
2 6 3
3 5 1
4 9 1
5 (Least deprived) 2 1
Smoking status (at time of interview):
Smoker 15 11
Ex-smoker (since around diagnosis) 14 3
Cancer type:
Head & Neck 10 N/A
Colorectal 7
Lung 7
Gynaecological 5
Time since diagnosis:
≤ 6 months 13 N/A
7–12 months 5
13–18 months 8
> 18 months 3
Treatment intent:
Radical 23 N/A
Palliative 6
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later telephoned to arrange an interview. Informed
consent was sought immediately before interview.
Interview sample: Sixty seven interviews were
conducted across the three participant groups:
 Sample 1: Twenty-nine patients with cancer who
were current smokers or recent ex-smokers (Table
2), from 58 who were approached. Joint interviews
were held with four patients/family members.
 Sample 2: Fourteen family members who were
current smokers or recent ex-smokers (Table 2).
 Sample 3: Twenty-four health professionals from
oncology, primary care and smoking cessation services
(Table 3). All those approached agreed to be
interviewed.
Data collection
Patient, family member and professional interviews
were conducted concurrently to allow emergent
themes to be explored between the groups in an
iterative fashion. Topic guides incorporated Leventhal’s
‘commonsense’ model [41] and advice from our patient
advisor in the research team (Table 4). Leventhal’s model
proposes that a person’s mental model of an illness has an
impact on behaviours in response to that illness, and
comprises: his or her sense of ‘illness identity’ (illness
diagnosis and associated symptoms); causes; timeline
(is the illness acute, chronic, or cyclical?); conse-
quences (e.g., social, financial); and control (the
degree to which the patient feels he or she has con-
trol over the illness) [42]. In relation to smoking be-
haviour within the cancer context, we sought to
examine the nature of the patients’ and family
members’ understanding of the link between cancer
diagnosis and prognosis and smoking behaviour. In-
terviews with patients and family members explored
their previous and current smoking behaviour and
beliefs, the place of smoking within family and wider
social networks and experiences of talking about
cancer and smoking following a personal or family
member’s cancer diagnosis. Interviews with health
professionals explored current practices, experiences,
concerns, opportunities and barriers to smoking
cessation. The acceptability, feasibility and potential fea-
tures of smoking cessation interventions for patients and
family members were also explored.
All interviews were conducted by an experienced quali-
tative researcher (PA), digitally-recorded and transcribed
verbatim. Most patient and family member interviews
took place in their own homes. Health professionals were
interviewed at a workplace location. Interviews lasted
between half an hour and 90 min. All participants were
reassured that interviews were confidential and that any
reported data would be anonymised.
Data analysis
Data were analysed using the constant-comparative
technique within the ‘Framework’ method [43]. Inter-
view transcripts were managed using NVIVO (v10).
Three members of the research team were involved in
reviewing transcripts and enabling identification of
emergent themes for subsequent exploration. An ana-
lysis Working Group (MW, PA, FH, GO) designed in-
terim coding frameworks, which Steering Group
Table 3 Characteristics of study participants (Health
Professionals)
Health Professionals
(n = 24)
Professional role:
Clinical Nurse Specialist 5
Medical Specialist (Consultant
Oncologist/Surgeon/Specialist Registrar)
5
General Practitioner 2
Senior Nurses (Consultant/Advanced
Practitioner/Team Leader/Senior Nurse)
6
Therapy Radiographers 2
Pharmacy (Oncology & community) 2
Oncology Support Worker 1
Member of NHS Smoking Cessation
Team
1
Work type:
Acute hospital 19
Community hospital or setting 5
Gender:
Female 17
Male 7
Table 4 Interview Topic Guide
Main topic areas
1. Context – participant’s experience and understanding of
diagnosis, care, treatment
2. Smoking behaviour and beliefs – smoking history, feelings and
beliefs about smoking, relationship with health
3. Smoking and social networks – views and behaviours of others
4. Attempts at smoking cessation – how these felt, use of services,
experiences
5. Accessing healthcare as a smoker – discussions about smoking/
cessation
6. Experiences of cancer and smoking – discussions, information,
support, connections made, changes in behaviour or feelings,
use of services, attitudes towards smoking now, family support,
difficulties and challenges
7. Views about smoking advice intervention for people with cancer
and families – what would work, not work, challenges, benefits
8. Feelings about the interview, talking about smoking
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members helped develop further after use on a selection
of finalised transcripts. PA and FH then applied the analyt-
ical framework to transcripts and captured subsequent,
emergent themes. Matrices and charts were used to com-
pare themes within and across participant groups and to
identify key analytical themes and supporting quotations.
Attention was paid to exploring a variation of views and
seeking explanations for disconfirming cases.
Results
Fifteen out of 29 patient participants and 11 out of 14
family members were current smokers at the time of
interview. The others all reported having stopped smok-
ing at or around the time of diagnosis. Qualitative inter-
views with patients and family members revealed several
barriers to smoking cessation and provided insights into
their experiences of and perceptions towards smoking
cessation services. Few participants had used UK (NHS)
smoking cessation services and some held negative views
as to their appropriateness. In addition, few participants
recalled meaningful discussions with health professionals
about smoking. Interviews with health professionals
revealed concerns about sensitivity, perceptions of respon-
sibility for talking about smoking, awareness of services
and views of potential facilitators to smoking cessation.
Three key themes emerged to explain patients’ and
family members’ continued smoking, and we present
these as barriers to smoking cessation. These include: the
stress experienced following a diagnosis; a desire to
maintain personal control and a sense of ‘normal’ self;
and lack of belief in or acceptance of the connection
between smoking, cancer and health. We illustrate each
theme with quotes from both patients and family mem-
bers, where appropriate. Quotes are coded as follows: P
(patient) or F (family member) – Study number – Type
of cancer (patients only) – Smoker or non-smoker. In-
formation on gender has been removed.
Stress experienced following diagnosis
The period following a diagnosis of cancer was experi-
enced as particularly stressful for patients and family
members. For some patients and family members, smok-
ing was used as a way of helping to cope with their stress.
‘[Stopping smoking is] very much in my mind at the
moment but I'm very unable to stop at the moment
because I'm a bit uptight about the chemotherapy and
family are here all the time and, while I feel well, I
feel quite stressed a lot of the time….I'm quite positive
about the treatment, but I do feel the need for a
cigarette sometimes.’ (P28-Colorectal-Smoker)
‘But I think [after diagnosis] at that time it was because
I wasn’t working…I had nothing else to do but think
about like “What’s this going to affect, what effect is it
going to have on the family?” and I think that built up a
stress which led me to smoking more.’ (P54-Gynae-
Smoker)
‘I can go one day without or two days without, I can
still stop smoking, but it's just when everything piles up
it's like a […] comfort, that's what it's like.’ (P47-
Head&Neck-Smoker)
…what's happened to [wife who has received cancer
diagnosis]] in the past six weeks, she’s went from a
normal life to what she’s got now and the smoking
helps me just to get over it…because I can go outside
and sit on my own and think about it…’ (F6-Smoker)
The degree to which smoking was perceived as a cop-
ing mechanism was highlighted by two patients, both of
whom identified a strong addictive element to their
smoking. For these patients, even thoughts of stopping
smoking aroused a stress response which they antici-
pated they would have difficulty dealing with.
‘…I just couldn’t get over that first hurdle not smoking,
if they [cigarettes] weren’t there I’d panic, honestly I
would.’ (P29-Lung-Smoker)
‘[…] I hate myself for smoking. I have got to stop. Now
the question is stopping in a way that causes me, but
more importantly my wife, the least distress because…
when I stop I can… be nasty, like I say, I’d pick a fight
with the sofa.’ (P10-Lung-Smoker)
A desire to maintain personal control
The desire to exercise personal control and choice over
smoking behaviour within the context of the cancer diag-
nosis emerged as an underlying barrier to cessation for
patients. Following diagnosis, patients who experienced
‘nagging’ or pressure by relatives to stop smoking
resisted and resented this, emphasising that a decision
to stop smoking was theirs alone. There was a sense in
which patients wanted to assert themselves and, for
some, the decision to continue smoking was a way of
doing this.
‘I think a little bit of it is so many people saying
“Stop”, that your mind is saying, “No, I’ll stop when I
want to”. I'm not having people telling me to stop.’
(P31-Head&Neck-Smoker)
‘But I’ll have my cousins and that saying “You
shouldn’t be smoking anyway”…and I just go “Yes,
whatever”. But, no, each to their own really.’ (P54-
Gynae-Smoker)
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‘I'm damned if I'm going to be told what to do by them
[family members].’ (P8-Colorectal-Smoker)
In contrast to the experience of some patients, the 11
family members who continued to smoke did not recall
experiencing significant pressure to stop smoking either
from their relative who had cancer or from other family
members.
Lack of ‘coherence’ between smoking, cancer and health
Patients who continued to smoke tended to express lim-
ited perceptions of and uncertainty about the risks and
consequences of smoking and, in turn, the benefits of
stopping. Where they made links between smoking and
health in their interviews, they expressed these primarily
in terms of smoking as a cause (or not) of cancer rather
than in relation to recovery or future health. In some in-
stances, patients explained and justified continued smok-
ing by drawing on messages received from healthcare
professionals which, they perceived, minimised the
connection between smoking and cancer diagnoses.
‘[Smoking’s] maybe a contributing factor, but it’s not
the entire cause. And I’ve just never thought along
those lines. I thought, well, it [cancer diagnosis] was
maybe meant to happen and that was that.’ (P26-
Colorectal-Smoker)
‘Even yet I maintain that it’s not the cigarettes [that
caused cancer].’ (P16-Head&Neck-Smoker)
‘I had cancer in the vagina, so it’s hardly related to my
cigarettes…and because it wasn’t related to the cancer,
my smoking, that's definitely why I didn't stop. If she
[health professional] had said to me [that it was
related to smoking] I’d have been off them […]’ (P17-
Gynae-Smoker)
While some patients did not acknowledge the causal
relationship between smoking and their cancer, others
thought that in the face of terminal illness or in light of
their smoking history, that it was ‘too late’ and that there
was little point in stopping. Indeed, when asked if they
thought there would be any impact on their health if
they stopped smoking, two participants told us,
‘No. I don’t think so…I really think that I’m too far
gone now…’ (P40-Lung-Smoker)
‘Well I honestly don't think it’ll do me any good, cause
I'm 69, I've been smoking for 59 years. I think it’ll
maybe do me more harm than good.’ (F6-Smoker)
The three family members in our study cohort who
had stopped smoking expressed that their decision to do
so had been influenced, in varying degrees, by a relative’s
cancer diagnosis and their subsequent perceptions about
the links between smoking and health. In contrast, rela-
tives’ cancer diagnoses, although clearly impacting emo-
tionally and in other ways, were less influential as a
motivator to stop smoking among family members who
continued to smoke. Stronger influences that were men-
tioned included the perceived reduction of the social
acceptability of smoking, caring responsibilities and cost.
‘Well, I’m going to have to try [to quit] because if they
keep putting the cigarettes up I’m not going to be able
to afford them, that’s the thing. (F12-Smoker-Also
diagnosed with lung cancer)
“I'm a mum, I can't stop for three days, I've still got to
carry on and do things. I've still got to cook dinner, I've
still got to - sometimes when I'm trying to quit I also
get very irritable” (F4 – – Smoker)
The impact of a terminal diagnosis on attitudes towards
stopping smoking was also seen in some health pro-
fessional responses, which are reported further below.
Experiences and perceptions of smoking cessation
services
Post-diagnosis, three of the 14 patients and each of
the three family members who had stopped smoking
reported doing so with varying degrees of support
from community-based pharmacy smoking cessation
services. Types of support included one-to-one
support with a community pharmacist or participation
in smoking cessation groups. Patients and family
members in this group emphasised particularly the
quality and person-centred relevance of information
provided by pharmacy smoking cessation services and
the effective interpersonal skills of smoking cessation
facilitators.
‘I mean, the girl [smoking cessation adviser] I spoke to,
she was brilliant. She was an ex-smoker, so she talked
about her own experience and the different routes you
could go and the different things they could give you,
the patches or the gum or […] the lozenges. We talked
about my smoking habits and what would be the best
route in relation to that.’ (P44-Lung-Ex-smoker)
‘Well, it [attending smoking cessation services] gave
me more incentive not to smoke because I had a
feeling that I’d let the nurse down if I had smoked
that week […] and the fact that she was an
ex-smoker herself was very good because she knew
exactly what I was going through.’ (P50-
Head&Neck-Ex-smoker)
Wells et al. BMC Cancer  (2017) 17:348 Page 6 of 15
‘I found the pharmacist very good because she
explained it all to me.’ (F10-Ex-smoker)
Among continuing smokers (15 patients and 11 family
members) just under half of each group stated an expli-
cit desire to stop smoking. Repeatedly, these patients
and family members expressed the belief that cessation
could only be achieved through willpower and they did
not indicate any consideration about using smoking ces-
sation services. However, based on their own experi-
ences, one patient (an ex-smoker) and one family
member (a continuing smoker) reflected on the ‘appro-
priateness’ of current cessation services for those af-
fected by a cancer diagnosis, particularly the lack of
privacy when services were delivered in pharmacies and
the repetitiveness of the generic ‘stop smoking’ message
which, perhaps, was not effective for those people
already affected by a cancer diagnosis.
‘[A pharmacy is not] great if there's not an adviser
there, and you're having to tell somebody in a very
public place you've got lung cancer. I didn't like that
bit of it.’ (F13-Smoker)
‘No, I’ve seen various numbers up on the ward in the
hospital to contact for [smoking cessation] advice and
all the rest of it, but I've been in touch with those
before and it's the same thing, they tell you the same
thing which you already know anyway.’ (P31-
Head&Neck-Smoker)
An additional, negative observation made by a
patient who had decided to stop smoking using will-
power rather than attend a smoking cessation group
was that ‘there were not enough hours in the day’ to
attend this type of service delivery regularly due to
the various demands on patients’ time following a
cancer diagnosis, particularly during treatment
periods.
Lack of meaningful discussion about smoking within the
oncology service
From patients’ and family members’ perspectives,
oncology staff rarely provided timely information
about, or direct referral to cessation services.
Around half of patients and most relatives recalled
little or no discussion with health professionals
about smoking.
‘No, I always thought it was very strange how nobody
ever said that I should stop smoking. I was waiting on
it, I was waiting on all of them saying “You should
really stop smoking”, nobody ever said it to me.’ (P3
-Colorectal, ex-smoker)
“I'm sitting here thinking once you'd [to wife] got
diagnosed with cancer the last time there was nobody
mentioned smoking….. [doctor’s name] knows that she
smokes. I don't think she approves, don't get me wrong,
she doesn't approve, there's nobody approves of you
smoking but nobody’s going to come along and change
that. You are a smoker and that's it.” (F2 - smoker).
Some patients had anticipated and would have been
receptive to staff being more proactive in encouraging
smoking cessation and service uptake, as long as this
was done sensitively and by the right person.
‘Even if the nurse just took that two minutes to say,
“Well we can help you. Have you ever thought about
giving up? We're not here to make you do it, but have
you ever thought about it?”.’ (P48-Gynae-Ex-smoker)
‘Thinking about it, why the hell was something not
done?. Well, obviously as I say, it’s up to the individual
again, but why did somebody not talk to me about it
[smoking cessation] or, you know, whatever? But no,
definitely nobody ever mentioned a thing. But I think
it may help if you had the right person doing it, I quite
believe it could help right enough. Definitely could.’
(P22-Lung-Smoker)
“I think probably it would’ve depended how they'd
done it. If it was somebody who I liked and had
confidence in and they did it the nice way, the right
way, I would’ve probably said ‘yes you're quite right,
we need to talk about this but not now when I'm ready
for it cause I need some help’. Had they done it the
wrong way, I can be fairly volatile…. I would be just
as likely… to turn around and say ‘look mate, I've got
enough on my mind at the moment knowing I could be
pushing up daisies in six months and frankly whether
I have another fag or not is totally immaterial to the
situation’, so it would’ve depended very much on the
person”. (P10 – Lung-Smoker)
Patients were sometimes uncertain about whether
family members who smoked should be involved in dis-
cussions about smoking cessation as they did not want
to add to family problems or felt it was their own deci-
sion, even if they wished that the family member did not
smoke. Although family members had not expected
healthcare staff to talk to them about smoking cessation,
many were open to discussing how they could support
patients to stop and also how they themselves could
access support.
‘Yes…I’d probably have been quite open if somebody
had phoned me or sent me a letter and said, you
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know, in the light of your brother’s diagnosis, or
whatever, would you want to consider at this time
getting some support for your own smoking. Yes, I
probably would.’ (F14-Smoker)
‘That’s something I would have jumped right on.
Although I wanted to quit to support [partner] more
than myself, at that particular moment, although I did
know I wanted to quit for myself too, it was because
my biggest fear at the time was he would start
smoking again and I didn’t want him to … I wanted
him to have the best chance’ (F4CS -smoker).
However, others were more resistant to being en-
gaged in discussions about smoking cessation. Indeed,
two family members felt that a direct approach from
staff was intrusive or risked exploiting people’s
vulnerability.
‘[It] maybe [is] a good idea but, at the same time,
you're catching… you'd be catching people at a real
low.’ (F6-Smoker)
‘I'm sorry but […] at the point when [wife] was diagnosed
with cancer, if somebody said to me “Well you'll need to
stop smoking now”, I would’ve went “Aye, well you go and
take a hike, sorry, I'm not in the frame of mind for that
one”.’ (F2GS-Smoker)
Participants, both patients and family members, sug-
gested that specific and directly-targeted hospital-based
cessation services, integrated with cancer treatment and
care, enabling patients and families to combine partici-
pation with routine hospital attendance would be more
likely to encourage successful uptake. However, our in-
terviews suggest that the barriers expressed by patients
and family members were often reinforced by health
professionals. The following section illustrates how
meaningful discussions about smoking and smoking
cessation were frequently absent.
Health professionals’ experiences and views
Overall, health professionals appeared to be more uneasy
about talking about smoking and smoking cessation than
were patients and family members. These were primarily
professionals who did not have smoking cessation as
their core or primary role (non-specialists). Their
concerns stemmed from their perceptions and beliefs
about the emotive and sensitive nature of the topic and
expectations about how patients might react. Lack of
opportunity for discussions, perceptions of their respon-
sibility for talking about smoking cessation and lack of
awareness about cessation services were also influential.
When they did talk about smoking, relatively few
discussed the benefits of cessation for future health. Very
few health professionals indicated that they ever dis-
cussed smoking or smoking cessation with family mem-
bers of people with cancer.
Smoking as a sensitive issue
Interviews with healthcare professionals indicated their
perceptions of smoking as a particularly sensitive issue
to broach around the time of a patient’s diagnosis. Pre-
dominantly, fears of implying, instilling or exacerbating
patients’ feelings of guilt about smoking made staff
hesitant about raising the issue. There was uneasiness
that arousing feelings of guilt could further upset pa-
tients already dealing emotionally with news of their
diagnosis.
‘[Patients] often may be feeling bad about it anyway,
because they feel that they’ve brought this diagnosis on
themselves because of their smoking habits, and
although I’m a non-smoker myself, and don’t advocate
smoking in any shape or form, I wouldn’t feel that it’s
my position then to start lecturing them about that.’
(S17-Specialist Nurse)
‘…you don't want to be seen like you're telling them off
or, you know, it’s already bad enough that they have a
potentially terminal illness.’ (S1- Specialist Nurse)
‘I think one of the issues you have to be quite careful
with is people are already beating themselves up
about what they may have done wrong and why they
are being punished by getting cancer. You don’t want
to compound any feelings of guilt or self-loathing by
preaching at them about their previous ‘evil ways’.’
(S8-Medical Specialist)
Staff also expressed concern that raising the issue of
smoking, particularly in the early stages of a cancer care
pathway, might imply judgement by healthcare profes-
sionals. Being viewed as non-judgemental was consid-
ered important for maintaining their professional role in
patients’ eyes and, for some staff, there was anxiety
about assuming what might be interpreted by patients as
a ‘policing’ role in relation to smoking.
‘[Smoking] is not something that at that point, at that
very first meeting, that's of any relevance because we
need to develop a rapport, they can't feel that we’re
being in any way judgemental or focusing on smoking.’
(S5- Specialist Nurse)
‘I think there’s too much anxiety. I think there’s an
element of guilt or feeling like a blame game, and I
think to, sort of, address it too aggressively up front
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can be detrimental to the doctor/patient relationship.’
(S7-Medical Specialist)
‘I think it was [staff] felt that they wanted to have a
positive relationship with the patient from the
beginning of their treatment, and that the patient
should be able to bring concerns to them, and that if
patients felt that they were policing their smoking that
they might not have that positive relationship with
them.’ (S16- Therapy Radiographer)]
Given the perceived sensitivity of smoking within the
context of a patient’s cancer diagnosis, the majority of
staff indicated the tendency to delay or avoid raising it.
During patients’ clinic attendance or treatment pre-
assessments, the question ‘Do you smoke?’ often had to
be asked alongside other lifestyle questions during com-
pletion of routine hospital documentation; however,
some staff acknowledged that this did not necessarily
lead to the initiation of discussion of the topic in any de-
tailed way, unless a patient indicated their openness to
engaging further in discussion about it. There was re-
peated mention by staff that they took a lead from pa-
tients themselves in their approach to talking about
smoking and it was perceived as less risky to the
clinician-patient relationship if the patient brought it up
as an issue themselves or if they sensed that the patient
was open to discussing it.
‘You know, I would ask if they smoke and if they said
‘Yes’, and, “Oh, have you ever thought of giving up?”.
Often, you get a flavour for where the patient is and
how the consultation’s going, but sometimes it’s
appropriate and sometimes it’s not been appropriate.
I think if the patient brings it up then it’s sort of open
goal if you like. It would be silly not to bring it up. ’
(S9-Medical Specialist)
‘..if there seems to be that actually there’s a readiness
there to engage with it, then you can have quite a good
conversation about options for smoking cessation and the
benefits and that type of thing.’ (S5- Specialist Nurse)
‘I mean, I think, [smoking’s] something that’s very much
on the agenda for discussing with patients but you have
to be guided by the patient’s reactions to you bringing up
the subject as well because there will be some who will
just not entertain the idea of even considering cutting
down, or anything, and you will have other patients who
are a bit more amenable to having discussions about it.’
(S21-Specialist Nurse).
When talking about how they approached the issue of
smoking, healthcare staff often drew a distinction
between patients with curable disease and those with in-
curable disease. This was an area where sensitivity about
smoking was particularly marked. Those healthcare staff
who mentioned this issue offered some explanations
about why they might not raise the issue of smoking
with patients with incurable cancer around the time of
diagnosis. Reasons included the assessment that smoking
may be a stress relief or coping mechanism for patients
and it may offer them personal enjoyment. Additionally,
within a palliative context smoking cessation may be
considered of lesser priority than others (e.g. pain relief ).
‘…when you’ve got a curable cancer where there is
good evidence that continuing to smoke will impact
negatively on cure rates then I really do bang on about
it and encourage them to quit….if we’re offering
treatment that is purely aimed at enhancing quality of
life then you may be doing them a dis-service getting
them to or persuading them to stop…I would ask them
if they smoked and obviously document a record of
their smoking habit. Would I bang on at them to stop?
No.’ (S10-Medical Specialist)
‘If a patient..were palliative in nature then I probably
wouldn’t pursue that, and maybe that’s wrong on my
part but reasons for that being if it’s palliative nature
and their lifespan isn’t long anyway and that’s
something they get enjoyment out of then I wouldn’t
feel that was my place to suggest that they stop doing
that.’ (S13-Specialist Nurse)
‘But I think sometimes I have felt maybe slightly guilty
bringing it up because I know that it is a stress
relieving thing. And I think maybe in the grand
scheme of things, in the bigger picture, actually in the
context of metastatic cancer, is it that important to
bring it up at that point?’ (S9-Medical Specialist)
Perceptions of responsibility for talking about smoking
cessation
Interviews suggested a picture of diffused responsibility
for tackling the issue of smoking. In a busy clinical en-
vironment, it was not necessarily perceived as part of
healthcare professionals’ role and there was reluctance
to ‘bombard’ patients/families with smoking cessation
messages.
’I think it’s better handled by other staff groups
than myself, if I’m absolutely honest. Again, to put
it into context, I’ve probably spent thirty or forty-
five minutes with a patient, they’ve had enough of
me, they’ve heard what I’ve got to say and to be
honest I just want to move on with my clinic.’
(S8-Medical Specialist)
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While most staff at least asked if patients smoked as
part of an initial assessment, very few followed this with
advice or support for cessation. Indeed, some health
professionals acknowledged their lack of awareness
of smoking cessation services and referral methods,
and others were unsure of who was actually tackling
the issue.
‘I’ve certainly seen doctors frequently – probably
nurses as well – advising patients not to smoke but
without actually giving them a strategy for doing so,
without giving them a contact detail.’ (S7-Medical
Specialist)
‘I’m…unaware of, you know, what other practitioners
are doing and…what’s already been said… so, it’s kind
of getting that sense that, perhaps, there’s very few
people talking about it because everybody thinks
everybody… There’s, like, an assumption being made
that it’s being discussed by everybody but in actual
fact it possibly isn’t so’ (S15 – Therapy Radiographer)
Discussions with family members about smoking
were rarely reported. Barriers included the absence
of family members in clinics, a focus on the patient,
limited contact time within oncology consultations
and underlying concerns about causing family
tensions. As the following quote illustrates, discus-
sions with family members about health were seen
as the individual’s choice rather than the clinician’s
priority.
‘…it’s not really something I've really thought about to be
quite honest but[…]unless another relative accompanies a
patient to an appointment or is present when we were
doing a home visit[…]it would be quite otherwise difficult
to engage with them ‘cause ultimately it’s up to their
choice whether they want to come to us and seek our
advice.’ (S3-GP)
Strategies used by health professionals to promote and
support smoking cessation
A minority of staff, those who approached the issue of
smoking with patients ‘head on’, reported ways to over-
come the barriers explored above. A key strategy was
providing clinical evidence on the adverse effects of
smoking on treatment outcomes and informing patients
about the benefits of stopping smoking on side-effects,
treatment outcomes and reduction in likelihood of
recurrence.
‘If I were raising it [smoking cessation] at all I would
raise it at the time I was explaining the treatment
because if I’m talking about side-effects, as I have
to[…] the side-effects are worse in people who smoke.’
(S8-Medical Specialist)
‘[I will say] your treatment will be much more
unpleasant if you carry on smoking, that your chance
of cure will be less if you carry on smoking […] you
have probably a one in three change of developing a
secondary primary, another cancer, at a later date
and that’s going to be higher if you carry on smoking. I
tend towards the stark. My style tends towards the
stark.’ (S19-Medical Specialist)
‘And maxillofacial, oral cancer, it’s generally the highest
contributory cause, so they are told “Smoking has given
you this disease in the first place”. And that’s what I say
to them, you know, “We can cure you of this, but you
have to give up smoking”’. (S5- Specialist Nurse)
One staff member, a surgeon, recognising the po-
tential sensitiveness of smoking cessation, saw this as
an impediment to the patient moving on in the care
pathway and attempted to ‘de-moralise’ the issue
quickly.
‘Some say “This is my entire fault doctor”. I don’t care
whose fault it was, we are going to move on from this.
This is not about blame, it’s not about preaching, it’s
not about telling you you’re a bad person, it’s about
what is best for you. So I try and keep it self-directed
and pragmatic and try and remove any moral or
value overly from it because I think it gets in the way.’
(S19-Medical Specialist)
A nurse showed how she introduced the topic of
smoking cessation as a ‘normal’ part of what is already a
personal conversation.
“With the cancer side we approach very personal issues
with regards to [for example] sexual dysfunction, so
talking about smoking, no I don't have an issue with
that whatsoever and do you know what I think the more
relaxed you are and incorporate it as a part of, I act like
I talk to everybody about it, absolutely everybody, this is
a normal part of what we do when we’re talking to
patients” (S23 – Specialist Nurse).
Another useful technique appeared to be one of infor-
mal, ‘positive reinforcement’ of behaviour change. A Spe-
cialist Nurse (S6) described how expressing delight at
smoking cessation attempts – ‘That’s great’, ‘That’s
fantastic’ – could, in her experience, provide encourage-
ment and support to patients.
Smoking cessation staff perceived a lack of explicit
commitment to the promotion of smoking cessation
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within oncology services, and emphasised that leadership
from consultant oncologists and a multidisciplinary
approach was needed to change the culture, so that
support to stop smoking became an integral part of the
care pathway.
‘It needs to come from the lead clinical management
networks right through, that this [support for smoking
cessation] has to be done as part of holistic care for
that patient, you know, and I find that very difficult in
each speciality that they don't have that part of
holistic care, you know, as part of an agenda.’ (S4-
Smoking Cessation Adviser)
A range of staff participants acknowledged that includ-
ing smoking cessation discussions within the context of
treatment plans was a more acceptable way of enhancing
patients’ perceptions of smoking risks and cessation ben-
efits. One of the main ways in which this was thought to
be possible was to improve links with the smoking cessa-
tion service within the hospital and to embed smoking
cessation professionals more explicitly into multidiscip-
linary cancer teams.
Discussion
To our knowledge, this is the first study in the UK to
explore multiple perspectives - patients, family members
and healthcare professionals - of the barriers and facilita-
tors to increasing uptake of smoking cessation services
within the context of a cancer diagnosis. Previous
studies have examined these perspectives in relation to
pregnant and new mothers, finding that women’s, part-
ners’ and health professionals’ views and experiences all
influence and challenge smoking cessation at a time that
might be considered an opportunity for positive behav-
iour change [44, 45]. Our findings suggest that in the
context of cancer care, smoking cessation support is cur-
rently insufficiently integrated into the care pathway and
does not fully meet the needs of people affected by
cancer. The low uptake of current smoking cessation
services among patients with cancer and their relatives
can be explained by a combination of individual, organ-
isational and system factors, which serve to limit oppor-
tunities for smoking cessation discussion and further
support. Therefore, interventions to improve uptake of
smoking cessation in this context must target systems as
well as individuals.
Many of the findings of this study are consistent with
previous research that has examined barriers and facili-
tators to smoking cessation and to accessing smoking
cessation services in a wide range of population groups
[45–48]. We believe these barriers need to be addressed
in any intervention to promote uptake of smoking cessa-
tion services in people with cancer.
In our study, patients and family members perceived
willpower or ‘doing it themselves’ as the best or most ap-
propriate way to stop. They viewed both licensed stop
smoking medications (such as Nicotine Replacement
Therapy) and behavioural support from services as un-
likely to work for them. This perception, leading to low
levels of service uptake, exists at the population level
[46, 47] and is not unique to cancer patients. However,
our study found that the emotional burden of a cancer
diagnosis and the time-consuming and demanding na-
ture of treatment meant that patients, family members
and health care professionals avoided talking about
smoking and that many opportunities for smoking cessa-
tion support were missed [47, 49]. As with other patient
groups, although participants appeared to expect some
mention or offer of discussions about smoking, many
healthcare professionals were fearful of damaging thera-
peutic relationships or felt that such discussions were
inappropriate or likely to be ineffective, therefore took
the line of least resistance. A predominant focus on
smoking as a cause of cancer appeared to emphasise
concerns about exacerbating potential guilt and blame
and inhibit discussions about smoking cessation as a
current and future-oriented means of taking control, im-
proving treatment outcomes and longer term health.
In terms of accessing smoking cessation services, pa-
tients and staff had poor understanding and low expec-
tations of what services could offer. There was limited
evidence that patients’, family members’ and health care
professionals’ made meaningful connections between
cancer, smoking and health [46, 50]. This served to fur-
ther reduce the likelihood that ‘teachable moments’ were
used and access to smoking cessation services promoted.
Furthermore, family members suggested that their loved
one’s cancer was not a sufficient motivator to stop smok-
ing and that other reasons, such as the cost of smoking,
were needed. Our findings confirm the ambivalent rela-
tionships between social support and smoking behav-
iour. Some family members who continue to smoke
distance themselves from the diagnosis by disputing the
link between smoking and disease, and many believe
strongly that smoking cessation is an individual choice
and that a decision to quit has to be motivated by the
‘right reason’ and initiated at the ‘right time’, not neces-
sarily as a reaction to life-threatening disease [51]. Con-
versely, and in agreement with Ochsner et al. [52], we
also found evidence that the support of close relatives
was an important factor in determining both intention
and ability to quit smoking.
Health professionals’, patients’ and family members’ ac-
counts of advice on smoking are also consistent with
previous research among other population groups [44,
53, 54]. Provision of information and advice on smoking
too often stopped after asking the questions about
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smoking status without progressing to providing advice
to stop or, crucially, an active referral to cessation ser-
vices. Some of this was attitudinal – staff did not view
advice or referral as appropriate for particular groups of
patients, for example, those receiving palliative treat-
ment. Other aspects related to knowledge – while staff
had a good understanding of the links between smoking
and lung cancer, and respiratory conditions like Chronic
Obstructive Pulmonary Disease (COPD), there was some
evidence that they either did not know or did not convey
links with some other cancers [55, 56]. Nor did they fully
appreciate the clear association between smoking cessa-
tion treatment outcomes and improved long term
health. There was also little or no mention of the under-
standing between second hand smoke exposure and can-
cer, which is relevant to the advice given to family
members as well as patients [57, 58]. This is an import-
ant issue that can be prevented through better training
and prioritisation of early and ongoing education on
smoking in clinical curricula and in practice. While
health professionals need to be sensitive to not blaming
patients for a cancer diagnosis, they should not mislead
or ignore possible links, thus inadvertently undermining
the opportunities that cessation can provide, including
secondary prevention. This means that education and
training must support the development of a more so-
phisticated understanding of their own biases, the pa-
tient’s personal beliefs and a confidence and ability to
engage in an ongoing process of supporting patients to
give up smoking. Discussions about how smoking can
make the side effects of treatment worse may provide a
useful route for clinicians to broach the topic of smoking
cessation but it is important that these go beyond using
the initial emotional trigger of the diagnosis and the mo-
tivational context that the clinical setting provides [5].
Other aspects were clearly organisational, where
advice and referral to smoking cessation was not priori-
tised and efforts were uncoordinated. We identified a
philosophical and organisational distinction, and there-
fore separation, between the clinical world of oncology
and the health promoting world of smoking cessation.
Multiple studies have illustrated that the chances of suc-
cessfully stopping double if licensed pharmacotherapies
on prescription are accessed, and double again if this is
combined with behavioural support of the type offered
by smoking cessation services in the UK and elsewhere
[59–61]. There is clearly an urgent need for greater pri-
oritisation and coordination of smoking cessation advice
and referral within cancer services. This requires action
at a number of levels, including closer working between
smoking cessation and cancer care professionals and im-
plementation of national guidance. In the UK, the NICE
(National Institute for Health and Care Excellence) guid-
ance for acute services [62] is particularly relevant, and
elsewhere, other smoking cessation guidance should be
applied [63, 64]. Current developments that affect how
patients and family members approach smoking cessa-
tion, including a rapid rise in the use in many countries
of e-cigarettes as an aid to smoking cessation, also needs
to be taken into account [65, 66].
There is an evident need for services, supported by
policy-makers, to better convey to the public (including
cancer patients and their family members) what can be
offered and how this will work. This requires greater tai-
loring of media campaigns (which have been poorly
resourced in a number of jurisdictions in recent years
[67, 68]) as well as more effective action and advice from
health professionals. Our study shows that where health
professionals used direct but supportive messages and
clear evidence to convey the importance of cessation for
individuals, this appealed to patients’ sense of coherence
about the role of smoking cessation on their health and
therefore helped to motivate smoking cessation. A study
of healthy women also found that providing a ‘coherent’
explanation of the link between smoking and cancer in-
creased both perceptions of vulnerability to cervical
cancer, and intentions to stop smoking [50]. Effective
tailoring of stop smoking messages and providing sup-
port for cessation is clearly important for smokers with
cancer, especially as patients often held the view that it
was up to them to stop smoking. Raising awareness of
the existence of the services and the potential for these
to address individual motivations for cessation also mat-
ters. Tools and resources to support evidence-based
messages and promote a more integrated, coherent and
consistent approach to smoking cessation across the
cancer pathway are a potential way forward.
Our study provides supporting insights that are con-
sistent with those of US researchers who have conducted
extensive research in this area [49]. A recent systematic
review and meta-analysis concluded that smoking cessa-
tion interventions that are delivered in clinical settings
are particularly effective, and recommended more re-
search into the challenges of integrating smoking cessa-
tion interventions into oncology settings [69]. This is
likely to require multi-disciplinary strategies that pay at-
tention to emotional, behavioural and practical issues, and
are personalised and proactive, as well as reactive [5].
There are some limitations to our study. Although our
sample was large and diverse, the generalizability of our
findings may be limited by the focus on one cancer
centre. We also experienced a number of challenges as-
sociated with recruiting family members, including
patients attending clinic appointments unaccompanied,
patients being reluctant to distribute information sheets
and family members not returning reply slips. To
mitigate these problems, we attended NHS smoking ces-
sation groups and used posters at a local cancer support
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centre and an advertisement in the local press to recruit
five additional participants.
Conclusions
Our study provides important insights into the specific
barriers and facilitators experienced in a UK/Scottish
context that may also be relevant to other countries. In
particular it illustrates the need for health service system
change as well as attention to education, training and
support for health care professionals. It is clear that pa-
tients and family members are likely to find it acceptable
for health care professionals to broach the subject of
smoking in supportive and constructive ways and that
individualised assessment and tailoring of smoking
cessation advice is crucial. A clear message from this
study is that efforts to integrate smoking cessation inter-
ventions more effectively into routine practice are
warranted and could pay dividends for patients and
family members.
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